APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ticagrelor

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ticagrelor Market Outlook and Growth Opportunities 2026

22 December 2025190 pages

Choose your research edition.

Industry ResearchTicagrelor Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Ticagrelor Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Ticagrelor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ticagrelor Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Ticagrelor Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Ticagrelor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ticagrelor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ticagrelor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ticagrelor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ticagrelor market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ticagrelor market include Sun Pharmaceutical, Johnson & Johnson, Merck, Eli Lilly, Pfizer, Bayer, Astrazeneca and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ticagrelor market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ticagrelor and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ticagrelor sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ticagrelor market size, projected growth trends, production technologies, key applications, and end-use industries.

Ticagrelor Segment by Company

Sun Pharmaceutical

Johnson & Johnson

Merck

Eli Lilly

Pfizer

Bayer

Astrazeneca

Boehringer Ingelheim

Ticagrelor Segment by Type

90 mg Tablet

60 mg Tablet

Ticagrelor Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Ticagrelor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ticagrelor status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Ticagrelor market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ticagrelor significant trends, drivers, influence factors in global and regions.

6. To analyze Ticagrelor competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ticagrelor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ticagrelor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ticagrelor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ticagrelor market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ticagrelor industry.

Chapter 3: Detailed analysis of Ticagrelor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Ticagrelor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Ticagrelor in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ticagrelor Industry Trends Table 2. Ticagrelor Industry Drivers Table 3. Ticagrelor Industry Opportunities and Challenges Table 4. Ticagrelor Industry Restraints Table 5. Global Ticagrelor Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ticagrelor Revenue Share by Company (2021-2026) Table 7. Global Ticagrelor Sales Volume by Company (k pcs) & (2021-2026) Table 8. Global Ticagrelor Sales Volume Share by Company (2021-2026) Table 9. Global Ticagrelor Average Price (US$/pcs) of Company (2021-2026) Table 10. Global Ticagrelor Company Ranking, (2024-2026) & (USD Million) Table 11. Global Ticagrelor Key Company Manufacturing Base & Headquarters Table 12. Global Ticagrelor Company, Product Type & Application Table 13. Global Ticagrelor Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Ticagrelor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 90 mg Tablet Table 18. Significant Companies of 60 mg Tablet Table 19. Global Ticagrelor Sales Volume by Type 2021 VS 2025 VS 2032 (k pcs) Table 20. Global Ticagrelor Sales Volume by Type (2021-2026) & (k pcs) Table 21. Global Ticagrelor Sales Volume by Type (2027-2032) & (k pcs) Table 22. Global Ticagrelor Sales Volume Share by Type (2021-2026) Table 23. Global Ticagrelor Sales Volume Share by Type (2027-2032) Table 24. Global Ticagrelor Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Ticagrelor Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Ticagrelor Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Ticagrelor Sales Value Share by Type (2021-2026) Table 28. Global Ticagrelor Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Pharmacies Table 30. Significant Companies of Online Pharmacies Table 31. Significant Companies of Retail Pharmacies Table 32. Global Ticagrelor Sales Volume by Application 2021 VS 2025 VS 2032 (k pcs) Table 33. Global Ticagrelor Sales Volume by Application (2021-2026) & (k pcs) Table 34. Global Ticagrelor Sales Volume by Application (2027-2032) & (k pcs) Table 35. Global Ticagrelor Sales Volume Share by Application (2021-2026) Table 36. Global Ticagrelor Sales Volume Share by Application (2027-2032) Table 37. Global Ticagrelor Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Ticagrelor Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Ticagrelor Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Ticagrelor Sales Value Share by Application (2021-2026) Table 41. Global Ticagrelor Sales Value Share by Application (2027-2032) Table 42. Global Ticagrelor Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Table 43. Global Ticagrelor Sales by Region (2021-2026) & (k pcs) Table 44. Global Ticagrelor Sales Market Share by Region (2021-2026) Table 45. Global Ticagrelor Sales by Region (2027-2032) & (k pcs) Table 46. Global Ticagrelor Sales Market Share by Region (2027-2032) Table 47. Global Ticagrelor Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Ticagrelor Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Ticagrelor Sales Value Share by Region (2021-2026) Table 50. Global Ticagrelor Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Ticagrelor Sales Value Share by Region (2027-2032) Table 52. Global Ticagrelor Market Average Price (US$/pcs) by Region (2021-2026) Table 53. Global Ticagrelor Market Average Price (US$/pcs) by Region (2027-2032) Table 54. Global Ticagrelor Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Table 55. Global Ticagrelor Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Ticagrelor Sales by Country (2021-2026) & (k pcs) Table 57. Global Ticagrelor Sales Market Share by Country (2021-2026) Table 58. Global Ticagrelor Sales by Country (2027-2032) & (k pcs) Table 59. Global Ticagrelor Sales Market Share by Country (2027-2032) Table 60. Global Ticagrelor Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Ticagrelor Sales Value Market Share by Country (2021-2026) Table 62. Global Ticagrelor Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Ticagrelor Sales Value Market Share by Country (2027-2032) Table 64. Sun Pharmaceutical Company Information Table 65. Sun Pharmaceutical Business Overview Table 66. Sun Pharmaceutical Ticagrelor Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 67. Sun Pharmaceutical Ticagrelor Product Portfolio Table 68. Sun Pharmaceutical Recent Development Table 69. Johnson & Johnson Company Information Table 70. Johnson & Johnson Business Overview Table 71. Johnson & Johnson Ticagrelor Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 72. Johnson & Johnson Ticagrelor Product Portfolio Table 73. Johnson & Johnson Recent Development Table 74. Merck Company Information Table 75. Merck Business Overview Table 76. Merck Ticagrelor Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 77. Merck Ticagrelor Product Portfolio Table 78. Merck Recent Development Table 79. Eli Lilly Company Information Table 80. Eli Lilly Business Overview Table 81. Eli Lilly Ticagrelor Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 82. Eli Lilly Ticagrelor Product Portfolio Table 83. Eli Lilly Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Ticagrelor Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 87. Pfizer Ticagrelor Product Portfolio Table 88. Pfizer Recent Development Table 89. Bayer Company Information Table 90. Bayer Business Overview Table 91. Bayer Ticagrelor Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 92. Bayer Ticagrelor Product Portfolio Table 93. Bayer Recent Development Table 94. Astrazeneca Company Information Table 95. Astrazeneca Business Overview Table 96. Astrazeneca Ticagrelor Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 97. Astrazeneca Ticagrelor Product Portfolio Table 98. Astrazeneca Recent Development Table 99. Boehringer Ingelheim Company Information Table 100. Boehringer Ingelheim Business Overview Table 101. Boehringer Ingelheim Ticagrelor Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 102. Boehringer Ingelheim Ticagrelor Product Portfolio Table 103. Boehringer Ingelheim Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Ticagrelor Distributors List Table 107. Ticagrelor Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Ticagrelor Product Image Figure 2. Global Ticagrelor Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ticagrelor Sales Value (2021-2032) & (US$ Million) Figure 4. Global Ticagrelor Sales (2021-2032) & (k pcs) Figure 5. Global Ticagrelor Sales Average Price (US$/pcs) & (2021-2032) Figure 6. Global Ticagrelor Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 90 mg Tablet Image Figure 10. 60 mg Tablet Image Figure 11. Global Ticagrelor Sales Volume by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 12. Global Ticagrelor Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Ticagrelor Sales Volume Share by Type (2021-2032) Figure 14. Global Ticagrelor Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Ticagrelor Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Ticagrelor Sales Value Share by Type (2021-2032) Figure 17. Hospital Pharmacies Image Figure 18. Online Pharmacies Image Figure 19. Retail Pharmacies Image Figure 20. Global Ticagrelor Sales Volume by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 21. Global Ticagrelor Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Ticagrelor Sales Volume Share by Application (2021-2032) Figure 23. Global Ticagrelor Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Ticagrelor Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Ticagrelor Sales Value Share by Application (2021-2032) Figure 26. Global Ticagrelor Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Figure 27. Global Ticagrelor Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Ticagrelor Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Ticagrelor Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Ticagrelor Sales Value (2021-2032) & (US$ Million) Figure 31. North America Ticagrelor Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Ticagrelor Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Ticagrelor Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Ticagrelor Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Ticagrelor Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Ticagrelor Sales Value (2021-2032) & (US$ Million) Figure 37. South America Ticagrelor Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Ticagrelor Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Ticagrelor Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Ticagrelor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Ticagrelor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Ticagrelor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Ticagrelor Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Ticagrelor Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 90 mg Tablet
  • 60 mg Tablet
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Sun Pharmaceutical
  • Johnson & Johnson
  • Merck
  • Eli Lilly
  • Pfizer
  • Bayer
  • Astrazeneca
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ticagrelor Sales Value (2021-2032)
  4. 1.2.2 Global Ticagrelor Sales Volume (2021-2032)
  5. 1.2.3 Global Ticagrelor Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Ticagrelor Market Dynamics
  1. 2.1 Ticagrelor Industry Trends
  2. 2.2 Ticagrelor Industry Drivers
  3. 2.3 Ticagrelor Industry Opportunities and Challenges
  4. 2.4 Ticagrelor Industry Restraints
3 Ticagrelor Market by Company
  1. 3.1 Global Ticagrelor Company Revenue Ranking in 2025
  2. 3.2 Global Ticagrelor Revenue by Company (2021-2026)
  3. 3.3 Global Ticagrelor Sales Volume by Company (2021-2026)
  4. 3.4 Global Ticagrelor Average Price by Company (2021-2026)
  5. 3.5 Global Ticagrelor Company Ranking (2024-2026)
  6. 3.6 Global Ticagrelor Company Manufacturing Base and Headquarters
  7. 3.7 Global Ticagrelor Company Product Type and Application
  8. 3.8 Global Ticagrelor Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Ticagrelor Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Ticagrelor Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Ticagrelor Market by Type
  1. 4.1 Ticagrelor Type Introduction
  2. 4.1.1 90 mg Tablet
  3. 4.1.2 60 mg Tablet
  4. 4.2 Global Ticagrelor Sales Volume by Type
  5. 4.2.1 Global Ticagrelor Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Ticagrelor Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Ticagrelor Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Ticagrelor Sales Value by Type
  9. 4.3.1 Global Ticagrelor Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Ticagrelor Sales Value by Type (2021-2032)
  11. 4.3.3 Global Ticagrelor Sales Value Share by Type (2021-2032)
5 Ticagrelor Market by Application
  1. 5.1 Ticagrelor Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Ticagrelor Sales Volume by Application
  6. 5.2.1 Global Ticagrelor Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ticagrelor Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Ticagrelor Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Ticagrelor Sales Value by Application
  10. 5.3.1 Global Ticagrelor Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Ticagrelor Sales Value by Application (2021-2032)
  12. 5.3.3 Global Ticagrelor Sales Value Share by Application (2021-2032)
6 Ticagrelor Regional Sales and Value Analysis
  1. 6.1 Global Ticagrelor Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ticagrelor Sales by Region (2021-2032)
  3. 6.2.1 Global Ticagrelor Sales by Region: 2021-2026
  4. 6.2.2 Global Ticagrelor Sales by Region (2027-2032)
  5. 6.3 Global Ticagrelor Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Ticagrelor Sales Value by Region (2021-2032)
  7. 6.4.1 Global Ticagrelor Sales Value by Region: 2021-2026
  8. 6.4.2 Global Ticagrelor Sales Value by Region (2027-2032)
  9. 6.5 Global Ticagrelor Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Ticagrelor Sales Value (2021-2032)
  12. 6.6.2 North America Ticagrelor Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Ticagrelor Sales Value (2021-2032)
  15. 6.7.2 Europe Ticagrelor Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Ticagrelor Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Ticagrelor Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Ticagrelor Sales Value (2021-2032)
  21. 6.9.2 South America Ticagrelor Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Ticagrelor Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Ticagrelor Sales Value Share by Country, 2025 VS 2032
7 Ticagrelor Country-level Sales and Value Analysis
  1. 7.1 Global Ticagrelor Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ticagrelor Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Ticagrelor Sales by Country (2021-2032)
  4. 7.3.1 Global Ticagrelor Sales by Country (2021-2026)
  5. 7.3.2 Global Ticagrelor Sales by Country (2027-2032)
  6. 7.4 Global Ticagrelor Sales Value by Country (2021-2032)
  7. 7.4.1 Global Ticagrelor Sales Value by Country (2021-2026)
  8. 7.4.2 Global Ticagrelor Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Ticagrelor Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Ticagrelor Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Ticagrelor Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Ticagrelor Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Ticagrelor Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Ticagrelor Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Ticagrelor Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Ticagrelor Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Ticagrelor Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Ticagrelor Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Ticagrelor Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Ticagrelor Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Ticagrelor Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Ticagrelor Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Ticagrelor Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Ticagrelor Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Ticagrelor Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Ticagrelor Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Ticagrelor Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Ticagrelor Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Ticagrelor Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Ticagrelor Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Ticagrelor Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Ticagrelor Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Ticagrelor Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Ticagrelor Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Ticagrelor Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Ticagrelor Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Ticagrelor Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Ticagrelor Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Ticagrelor Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Ticagrelor Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Ticagrelor Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Ticagrelor Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Ticagrelor Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Ticagrelor Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Ticagrelor Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Ticagrelor Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Ticagrelor Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Ticagrelor Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Ticagrelor Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Ticagrelor Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Ticagrelor Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Ticagrelor Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Ticagrelor Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Ticagrelor Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Ticagrelor Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Ticagrelor Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Ticagrelor Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Ticagrelor Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Ticagrelor Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Ticagrelor Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Ticagrelor Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Ticagrelor Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Ticagrelor Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Ticagrelor Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Ticagrelor Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Ticagrelor Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Ticagrelor Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Ticagrelor Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Ticagrelor Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Ticagrelor Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Ticagrelor Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Ticagrelor Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Ticagrelor Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Ticagrelor Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Ticagrelor Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Ticagrelor Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Ticagrelor Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Ticagrelor Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Ticagrelor Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Ticagrelor Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Ticagrelor Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Ticagrelor Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Ticagrelor Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Ticagrelor Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Ticagrelor Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Ticagrelor Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Ticagrelor Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Ticagrelor Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Ticagrelor Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Ticagrelor Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Ticagrelor Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Ticagrelor Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharmaceutical
  2. 8.1.1 Sun Pharmaceutical Company Information
  3. 8.1.2 Sun Pharmaceutical Business Overview
  4. 8.1.3 Sun Pharmaceutical Ticagrelor Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharmaceutical Ticagrelor Product Portfolio
  6. 8.1.5 Sun Pharmaceutical Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Ticagrelor Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Ticagrelor Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Ticagrelor Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck Ticagrelor Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Eli Lilly
  20. 8.4.1 Eli Lilly Company Information
  21. 8.4.2 Eli Lilly Business Overview
  22. 8.4.3 Eli Lilly Ticagrelor Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Eli Lilly Ticagrelor Product Portfolio
  24. 8.4.5 Eli Lilly Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Ticagrelor Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Ticagrelor Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Bayer
  32. 8.6.1 Bayer Company Information
  33. 8.6.2 Bayer Business Overview
  34. 8.6.3 Bayer Ticagrelor Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Bayer Ticagrelor Product Portfolio
  36. 8.6.5 Bayer Recent Developments
  37. 8.7 Astrazeneca
  38. 8.7.1 Astrazeneca Company Information
  39. 8.7.2 Astrazeneca Business Overview
  40. 8.7.3 Astrazeneca Ticagrelor Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Astrazeneca Ticagrelor Product Portfolio
  42. 8.7.5 Astrazeneca Recent Developments
  43. 8.8 Boehringer Ingelheim
  44. 8.8.1 Boehringer Ingelheim Company Information
  45. 8.8.2 Boehringer Ingelheim Business Overview
  46. 8.8.3 Boehringer Ingelheim Ticagrelor Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Boehringer Ingelheim Ticagrelor Product Portfolio
  48. 8.8.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ticagrelor Value Chain Analysis
  2. 9.1.1 Ticagrelor Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ticagrelor Sales Mode & Process
  6. 9.2 Ticagrelor Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ticagrelor Distributors
  9. 9.2.3 Ticagrelor Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst